Delivery Order SPE2DB22D9239-SPE2DB25FDJ83
Award Date
6/3/25
Potential Completion Date
6/25/25
Potential Value
$36K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $36,458.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. The contract is not associated with a set-aside designation. It is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $34,039.68 and has an ultimate completion date of July 19, 2024. The contract is for the delivery of the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML, with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $45,572.70 and an ultimate completion date of March 17, 2025. The award is for the delivery of 4567394636 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business organization. The contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML, a pharmaceutical product, with a potential value of $8,509.92 and a completion date of February 23, 2024. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $25,529.76, is for the delivery of PERJETA (420 mg/14 ml) vials to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a quantity of the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML. The potential value of this delivery order is $51,059.52, with a completion date of February 12, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds numerous federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $27,343.62 and a period of performance through February 19, 2025. It is for the procurement of 4567104411 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563188467 - PERJETA 420 MG/14 ML VIAL 14ML. The delivery order has a potential value of $41,385.00 and is scheduled for completion by January 18, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The $25,529.76 contract is for the supply of 4564110226 PERJETA 420 MG/14 ML VIAL 14ML, with a performance period through April 16, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDV) with the DLA, valued up to $4,999,999 through 2025, which enables the agency to...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,254.96 award is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology drug, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA...